![]() |
市场调查报告书
商品编码
1970643
气动止血带市场-全球产业规模、份额、趋势、机会、预测:按类型、应用、地区和竞争格局划分,2021-2031年Pneumatic Tourniquet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F |
||||||
全球气动止血带市场预计将从 2025 年的 11.2 亿美元成长到 2031 年的 17.8 亿美元,复合年增长率为 8.03%。
这些医疗设备旨在透过向周围袖带充入压迫气体,在手术过程中暂时阻断特定肢体的血液供应,从而建立无血的手术环境。市场扩张的主要驱动力是全球整形外科和创伤手术(尤其是关节关节重建和四肢重建)数量的增长,而人口老化是推动这一增长的主要因素。美国整形外科医学会发布的2024年美国关节关节重建登记数据显示,手术数量较上年度增长了18%,这印证了上述趋势,也凸显了对需要这些重要止血器械的手术干预措施日益增长的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 11.2亿美元 |
| 市场规模:2031年 | 17.8亿美元 |
| 复合年增长率:2026-2031年 | 8.03% |
| 成长最快的细分市场 | 单囊止血带 |
| 最大的市场 | 北美洲 |
另一方面,止血带可能引发的併发症,例如因长时间充气或压力过大导致的软组织坏死和神经麻痹,对市场成长构成重大障碍。这些临床风险要求严格遵守安全指南,并可能阻碍在复杂、耗时较长的手术中使用气动止血系统,因为持续的血流限制会对患者康復带来难以承受的风险。因此,这些安全隐患限制了该设备在某些高风险手术场景中的应用,从而阻碍了市场扩张。
运动相关损伤和整形外科损伤发生率的上升是全球气动止血带市场的主要驱动力。随着参与高强度健身和休閒运动的人数增加,需要手术修復的肌肉骨骼损伤也随之增加。韧带重组和骨折固定等手术高度依赖气动止血带来确保无血手术视野,从而提高手术精度并缩短手术时间。根据美国国家安全委员会的「伤害统计」资料库(2024年),与运动器材和活动相关的伤害年增17%,显示需要此类医疗干预的创伤病例激增。这有效地推动了全球对止血控制设备的需求。
同时,老年人口的增长及其对肌肉骨骼护理的需求显着提升了市场需求。随着全球人口老化,骨关节炎等退化性关节疾病的盛行率不断上升,导致对关节重建手术的需求增加,而这些手术需要先进的止血带系统来固定植入和控制出血。 2024年10月,美国整形外科学会在《肩肘关节註册年度报告》中指出,提交的手术数量较2022年报告增加了44%,凸显了肢体功能恢復手术需求的激增。这一趋势也反映在生产数据中;捷迈生物(Zimmer Biomet)于2024年2月发布的《2023年度报告》显示,其年度净销售额增长了6.5%。这主要归功于择期手术的持续成长。
全球气动止血带市场面临的主要障碍是软组织坏死和神经麻痹等併发症的风险。这些临床风险源自于过高的袖带压力或过长的缺血时间,迫使外科医生严格限制止血带的使用时间,使得气动止血带不适用于复杂、耗时较长的四肢重建手术,而这些手术对止血的要求至关重要。这种功能上的限制显着降低了止血带在以金额为准、长时间手术中的应用,迫使医疗机构选择其他止血方法,以最大限度地减少患者损伤和相关责任。
此外,难以维持严格的安全通讯协定是限制市场普及的另一个因素。在动态的手术环境中设定最佳压力仍然是一项操作上的挑战。近期的临床审核凸显了这个挑战。例如,2024年,英国皇家外科医师学会在其对英国整形外科医师英国安全标准进行的品质改进评估中报告称,在观察到的整形外科创伤病例中,正确应用推荐充气压力的比例不足33%。如此高的不合规率凸显了该设备固有的安全隐患,并直接阻碍了在安全至关重要的外科领域中的市场成长。
个人化肢体阻断压力(LOP)技术的普及正在从根本上重塑市场格局。该技术以患者个体化的校准取代了任意的压力设定。现代气动系统利用演算法,根据每条肢体的独特特征自动确定止血所需的最小有效压力,从而显着降低了人工估算造成的神经损伤风险。这种以安全为中心的资本设备趋势正在推动领先製造商的成长。例如,史赛克公司在2024年4月发布的「2023年综合报告」中指出,其有机销售额增长超过11%,并将这一增长归功于其配备先进安全功能的医疗和外科产品组合的强劲表现。
同时,为消除可重复使用医疗设备所带来的交叉感染风险,医疗机构正迅速转向使用一次性无菌抛弃式。医疗机构正在加速从传统的可重复使用袖带过渡到无菌抛弃式产品,以符合严格的感染控制标准,尤其是在手术区域无菌至关重要的关节重建手术中。这些预防措施的临床价值巨大;根据感染控制与流行病学专业人员协会 (APIC) 2024 年 6 月发布的报告《手术部位感染率显着降低》,应用全面的无菌包使全髋置换术的手术部位感染率显着降低了 32.8%,凸显着了一次性解决方案的必要性。
The Global Pneumatic Tourniquet Market is projected to expand from USD 1.12 Billion in 2025 to USD 1.78 Billion by 2031, reflecting a compound annual growth rate of 8.03%. These medical devices are engineered to temporarily obstruct blood circulation to specific limbs during surgery by inflating a surrounding cuff with compressed gas, thereby establishing a clear, bloodless operating environment. Market progression is primarily fueled by the rising global frequency of orthopedic and trauma surgeries, specifically joint replacements and limb reconstructions necessitated by an aging demographic. Highlighting this trend, the American Joint Replacement Registry, as noted by the American Academy of Orthopaedic Surgeons in 2024, recorded an 18% rise in procedural volumes compared to the prior year, emphasizing the growing need for surgical interventions requiring these essential hemostatic tools.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.12 Billion |
| Market Size 2031 | USD 1.78 Billion |
| CAGR 2026-2031 | 8.03% |
| Fastest Growing Segment | Single-Bladder Tourniquets |
| Largest Market | North America |
Conversely, market growth faces a notable obstacle regarding the potential for tourniquet-related complications, such as soft tissue necrosis and nerve paralysis, which result from prolonged inflation or excessive pressure. These clinical dangers mandate rigorous adherence to safety guidelines and can discourage the utilization of pneumatic systems during lengthy or complex operations where sustained blood flow restriction presents an intolerable risk to patient recovery. Consequently, these safety concerns restrict the application of these devices in certain high-risk surgical scenarios, acting as a constraint on broader market expansion.
Market Driver
The escalating incidence of sports-related and orthopedic injuries acts as a major catalyst for the Global Pneumatic Tourniquet Market. As engagement in high-intensity fitness and recreational sports increases, there is a parallel rise in musculoskeletal trauma that demands surgical repair. Procedures such as ligament reconstructions and fracture fixations depend heavily on pneumatic tourniquets to create a bloodless field, which enhances surgical precision and shortens procedure durations. According to the National Safety Council's 'Injury Facts' database in 2024, injuries associated with exercise equipment and activities rose by 17% over the previous year, signaling a surging volume of trauma cases requiring such medical interventions and effectively driving the global need for hemorrhage control devices.
Concurrently, the expanding geriatric population requiring musculoskeletal care is significantly strengthening market demand. As the global population ages, the prevalence of degenerative joint diseases like osteoarthritis rises, frequently necessitating joint replacement surgeries that require advanced tourniquet systems for implant fixation and blood loss management. In October 2024, the American Academy of Orthopaedic Surgeons reported in the 'Shoulder & Elbow Registry Annual Report' that submitted procedures increased by 44% compared to the 2022 report, illustrating the sharp rise in demand for restorative limb surgeries. This trend is mirrored in manufacturing data; Zimmer Biomet's '2023 Annual Report', released in February 2024, noted a 6.5% rise in annual net sales, attributed largely to the sustained recovery of elective surgical procedures.
Market Challenge
A significant barrier to the Global Pneumatic Tourniquet Market is the risk associated with complications such as soft tissue necrosis and nerve paralysis. These clinical hazards, resulting from excessive cuff pressure or prolonged ischemia, force surgeons to strictly cap the duration of device use, thereby making pneumatic tourniquets inappropriate for lengthy, complex limb reconstruction surgeries where hemostasis is vital. This functional limitation substantially diminishes the device's applicability in high-value, long-duration operations, compelling healthcare facilities to select alternative hemostatic agents to minimize patient injury and associated liability.
Moreover, the difficulty of maintaining rigorous safety protocols restricts broader market adoption, as achieving optimal pressure settings in dynamic surgical settings remains operationally challenging. This struggle is highlighted by recent clinical audits; for instance, the Royal College of Surgeons of England reported in 2024 that a quality improvement evaluation concerning British Orthopaedic Association safety standards found that recommended inflation pressures were correctly applied in less than 33% of observed orthopedic trauma cases. Such high rates of non-compliance emphasize the inherent safety difficulties of the device, directly hindering market growth within safety-critical surgical sectors.
Market Trends
The market is being fundamentally reshaped by the widespread adoption of Personalized Limb Occlusion Pressure (LOP) technology, which replaces arbitrary pressure settings with patient-specific calibration. Modern pneumatic systems now employ algorithms to automatically determine the minimum effective pressure needed for hemostasis based on unique limb characteristics, thereby significantly lowering the risk of nerve paralysis linked to manual estimation. This transition toward safety-focused capital equipment is driving growth for major manufacturers; for example, Stryker reported in its April 2024 '2023 Comprehensive Report' that organic sales grew by over 11%, a surge attributed to the strong performance of medical and surgical portfolios containing these advanced safety features.
Simultaneously, there is a rapid shift toward single-use sterile disposable cuffs, driven by the need to eradicate cross-contamination risks associated with reusable medical devices. Healthcare facilities are increasingly swapping traditional reusable cuffs for sterile disposable options to comply with strict infection control standards, especially for critical joint replacements where site sterility is essential. The clinical value of such preventive measures is significant; according to the Association for Professionals in Infection Control and Epidemiology's June 2024 report, 'Surgical Site Infection Rates Decrease Dramatically', the application of comprehensive sterile bundles led to a statistically significant 32.8% reduction in surgical site infection rates for hip arthroplasty procedures, highlighting the necessity of disposable solutions.
Report Scope
In this report, the Global Pneumatic Tourniquet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pneumatic Tourniquet Market.
Global Pneumatic Tourniquet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: